Ping Cheung Lam
Chairman at MINGYUAN MEDICARE DEVELOPMENT CO., LTD.
Ping Cheung Lam active positions
Companies | Position | Start | End |
---|---|---|---|
MINGYUAN MEDICARE DEVELOPMENT CO., LTD. | Chairman | 20/05/2016 | - |
Career history of Ping Cheung Lam
Former positions of Ping Cheung Lam
Companies | Position | Start | End |
---|---|---|---|
OSHIDORI INTERNATIONAL HOLDINGS LIMITED | Director/Board Member | 27/03/2012 | 21/05/2015 |
Independent Dir/Board Member | 27/03/2012 | 21/05/2015 | |
GOLDEN RESOURCES DEVELOPMENT INTERNATIONAL LIMITED | Director/Board Member | 13/10/2011 | 30/08/2012 |
Independent Dir/Board Member | 13/10/2011 | 30/08/2012 | |
SEAMLESS GREEN CHINA (HOLDINGS) LIMITED | Director/Board Member | 01/01/2010 | 04/08/2011 |
C C LAND HOLDINGS LIMITED | Director/Board Member | - | 22/06/2006 |
Lam & Co. (Hong Kong) | Founder | - | - |
Corporate Officer/Principal | - | - |
Training of Ping Cheung Lam
The Chinese University of Hong Kong | Undergraduate Degree |
Statistics
International
Hong Kong | 8 |
Operational
Director/Board Member | 4 |
Independent Dir/Board Member | 2 |
Undergraduate Degree | 1 |
Sectoral
Finance | 3 |
Retail Trade | 2 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 4 |
---|---|
C C LAND HOLDINGS LIMITED | Finance |
GOLDEN RESOURCES DEVELOPMENT INTERNATIONAL LIMITED | Retail Trade |
SEAMLESS GREEN CHINA (HOLDINGS) LIMITED | Electronic Technology |
OSHIDORI INTERNATIONAL HOLDINGS LIMITED | Finance |
Private companies | 2 |
---|---|
Lam & Co. (Hong Kong) | |
Mingyuan Medicare Development Co. Ltd.
Mingyuan Medicare Development Co. Ltd. BiotechnologyHealth Technology Mingyuan Medicare Development Co. Ltd. engages in provision of medicare solutions for the early detection and prevention of diseases particularly in China. It operates through the following segments: Protein Chips, Healthcare, Medical Centers Management, Individualized Target Therapy, and Bio-Drugs. The Protein Chips segment manufactures and distributes C-12 products to hospitals, medical centers, and life insurance companies in China. The Healthcare segment engages in the provision of sales and marketing campaign for HPV DNA testing kits and making important progress to register products for distribution to female patients at hospitals nationwide. The Medical Centers Management segment engages in the provision of healthcare services for residents living in cities. The Individualized Target Therapy segment specializes in molecular diagnostic kits for leukemia, lymphoma and individualised target cancer therapy. The Bio-Drugs segment engages in the development, production and commercialization of a new generation of non-specific nanotechnology immunomodulatory drugs known as non-cell Corynebacterium pavum products. The company was founded on May 8, 1989 and is headquartered in Hong Kong. | Health Technology |
- Stock Market
- Insiders
- Ping Cheung Lam
- Experience